Concept Medical Granted “Breakthrough Device Designation” by FDA for MagicTouch PTA Sirolimus Coated Balloon
Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK).
Concept Medical Inc. is backed by cardiologist, philanthropist and serial entrepreneur Dr. Kiran Patel, a staunch supporter of innovative and disruptive medical devices, providing breakthrough treatments to the people of the world. Under the leadership of drug delivery pioneer Dr. Manish Doshi, the company has initiated an extensive range of worldwide clinical programs to create evidence for its innovative drug delivery devices.
Concept Medical Inc has pioneered the Sirolimus drug delivery platform technology (Nanolute Technology) which has a proven commercial history in the coronary applications in more than 30,000 patients worldwide. MagicTouch PTA Sirolimus coated balloon is developed using this Nanolute Technology for use in PAD.
In an ongoing clinical study (XTOSI), Associate Professor Edward CHOKE, Principal Investigator of the study and Chief of Vascular Surgery, Sengkang General Hospital, Singapore, said, “study is the world’s first pilot study to investigate the safety and efficacy of novel MagicTouch PTA Sirolimus drug coated balloon (SCB) in the treatment of below the knee arterial lesions in addition to femoropopliteal lesions. The majority of patients enrolled had major comorbidities (diabetes and end stage renal failure) and the indication for angioplasty was for severe critical limb ischemia (more than 90% had the most severe Rutherford scores of 5 or 6). The extent of peripheral arterial disease treated were also severe, and about 80% of patients did not have any patent below the knee arteries before angioplasty. I am very encouraged by the excellent results so far in these challenging cohort of patients. Device and technical success were both 100%. Freedom from device and procedure related mortality was 100%. Limb salvage rate at 30 days was 97%. At 6 months, freedom from clinically driven target lesion revascularization (TLR) was 91%; and primary patency, independently and blindly assessed by duplex ultrasound, was 82%. I did not encounter any distal embolization or 'slow flow phenomenon' after application of SCB in BTK vessels.”
Dr. Sahil PARIKH, an interventional cardiologist and Associate Professor of Medicine and Director of Endovascular Services at the Columbia University College of Physicians and Surgeons, said, “The breakthrough designation demonstrates how important it is for us to have new technologies for BTK intervention. Patients with Critical Limb Ischemia (CLI) represent an enormous burden to our healthcare system and comprehensive care for these patients begins with effective revascularization. The MagicTouch PTA will hopefully bring us closer to our goals of reducing amputations in the US and the world.”
Peripheral vascular disease is a circulatory problem in which the peripheral blood vessels – usually the arteries of the legs – are starved of blood supply due to narrowing, blockage or spasm of the supplying blood vessels. If peripheral vascular disease (PVD) occurs only in the arteries, it is called peripheral artery disease (PAD). Most of the times PAD results from narrowing of the lumen of the blood vessels caused by inflammation, plaque buildup, or tissue damage. Diabetes is a major risk factor for PAD - more than 85% of patients with diabetes will develop PAD in their lifetime. CLI is a manifestation of peripheral arterial disease that occurs as chronic ischemic rest pain or ischemic skin lesions, ulcers, or gangrene. Infra-popliteal or below-the-knee (BTK) atherosclerotic arterial disease, either alone or combined with aortoiliac and femoropopliteal vascular disease, is the leading cause of critical limb ischemia and resultant amputations. Peripheral Arterial Disease (PAD) affects over 8 million people in the United States alone.
The breakthrough device designation granted to MagicTouch PTA offers Concept Medical Inc. an opportunity to interact with the FDA’s experts through several different program options to efficiently address topics as they arise during the premarket review phase, which can help manufacturers receive feedback from the FDA and identify areas of agreement in a timely way. Manufacturers can also expect prioritized review of their submission. Under the program, FDA will provide CMI with priority review and interactive communication regarding device development and clinical trial protocols, through to commercialization decisions. The first ‘Breakthrough Device Designation’ received by Concept Medical Inc. was on 30th April 2019 for its MagicTouch SCB, for the treatment of Coronary Artery Disease (CAD) in patients with in-stent restenosis.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons Launches Playond: the Mobile Gaming Service for Everybody15.11.2019 13:30:00 EET | Press release
Bending Spoons, Europe’s number one iOS mobile app developer, has officially launched Playond. This new gaming service gives members unlimited access to an ever-growing catalog of critically acclaimed premium games. The current collection of 60+ games is now available to everybody: Users can play for free with some limitations, or subscribe for an early bird price of $0.99/month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191115005141/en/ (Photo: Bending Spoons) “We are thrilled to have partnered with some of the most dedicated game developers and indie studios in the world. Playond is a service created by mobile gamers, for mobile gamers: our mission is bringing premium games on the App Store to as many players as possible, ultimately leveling-up the mobile gaming experience we can all enjoy" says Mauro Bolis, Project Manager of Playond. In recent years, free-to-play games designed to maximize ad impressions and in-app
Boyaa Poker Tournament Europe 2019. Ticketing Final Countdown15.11.2019 13:18:00 EET | Press release
Boyaa Poker Tournament Europe 2019 will take place from December 5 to 8 at King's Resort with a guaranteed prize of € 200,000. If you want a ticket, hurry up because the final countdown is ticking. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191115005139/en/ (Photo: Business Wire) An Asian experience recommended by European players Boyaa Interactive (Stock code 0434.HK) organized the first BPT in 2015 as a way to enrich its online social poker game and to reach its users worldwide, particularly in Southeast Asia. Now, this BPT comes to Europe for its sixth edition with an interesting proposal that includes a more cheerful and modern image than usual poker tournaments, side events with different buy-ins levels, and flashy trophies for the winners. Some European poker players that participated in previous BPT editions highlighted the diversity of countries that are usually represented in the BPT tournaments, and how the hos
Hagiwara Solutions to Exhibit at SPS 201915.11.2019 12:00:00 EET | Press release
Hagiwara Solutions Co., Ltd. (Elecom group) will exhibit at sps – smart production solution from the 26th to 28th of November 2019, Trade Fair Nuremberg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191115005082/en/ Introduction Map (Graphic: Hagiwara Solutions) Hagiwara Solutions Co., Ltd. is with Elecom group which is offering solutions with sensing technologies, industrial computers, and SSDs. D-Clue Technologies Co., Ltd. of Elecom group which is good for sensing technologies will join us at sps. SEVEN solutions for your own: Coolant Contamination Detection: How do you manage machine tool coolant for precise products? You can maintain the coolant correctly, using our live sensing system. Let us suggest you make precise products with our coolant contamination detection system. AR Goggle Devices: How do you browse reference documents during your tasks? Workers with our AR goggles don’t need to worry about it. The AR gogg
At CIIE 2019 Panasonic Showcases Solutions to Help Bring to Life China's "Healthy China 2030" Vision15.11.2019 07:22:00 EET | Press release
Panasonic Corporation took part in the 2nd China International Import Expo (CIIE) 2019, which was held in Shanghai from November 5 to 10. Under the theme, "Limitless Care for Healthy Living," Panasonic showcased health and welfare products and solutions that reflect its unique health values. With these products and solutions for a healthy life and aging society, Panasonic aspires to help bring to life China's "Healthy China 2030" vision. Panasonic also introduced its cutting-edge technologies that contribute to the business scene. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005958/en/ Panasonic booth at CIIE 2019 (Photo: Business Wire) [Video] #CIIE 2019 Panasonic Highlights - The 2nd China International Import Expo https://youtu.be/CbvZClNirQc Panasonic Booth Highlights Solutions for a Healthy Life and an Aging Society 1. "Healthy Environment Unit" With the evolution of sensing and data analytics technology, spaces
Alibaba Group Launches Hong Kong Initial Public Offering15.11.2019 01:47:00 EET | Press release
Alibaba Group Holding Limited (NYSE: BABA) (“Alibaba” or “the Company”) today announced the launch of its Hong Kong public offering (the “Public Retail Offering”), which forms part of the global offering (the “Offering”) of 500,000,000 new ordinary shares (the “Shares”) and listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “SEHK”) under the stock code “9988.” The Company’s American depositary shares (“ADSs”), each representing eight ordinary shares of the Company, will continue to be listed and traded on the New York Stock Exchange (“NYSE”). Upon listing in Hong Kong, the Hong Kong-listed shares will be fully fungible with the ADSs listed on the NYSE. “Alibaba is guided by our mission to make it easy to do business anywhere with the vision to be a good company that lasts for 102 years. We aim to serve global consumers, of which more than 1 billion will be Chinese consumers, and facilitate more than RMB10 trillion of consumption on our plat
ABI Research Names PTC a Leader in Enterprise Augmented Reality Platforms14.11.2019 22:05:00 EET | Press release
PTC (NASDAQ: PTC) today announced it has been named a leader in the Enterprise Augmented Reality Platforms market for its Vuforia® augmented reality (AR) solution suite in a new research report from ABI Research entitled, “Competitive Assessment – Enterprise Augmented Reality Platforms.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005759/en/ ABI Research Names PTC a Leader in Enterprise Augmented Reality Platforms (Graphic: Business Wire) The ABI Research report evaluated vendors on two criteria – innovation and implementation. ABI Research ranked Vuforia first in the innovation category due to PTC’s expansive customer and partner footprint, its advancements in transformative technology and functionality, and the company’s robust digital thread capability. In the implementation category, the ABI Research report highlighted Vuforia’s strength in device support, as well as “options from low-level development tools up
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom